Skip to main content

Table 1 Patient characteristics

From: Reverse remodeling of tricuspid valve morphology and function in chronic thromboembolic pulmonary hypertension patients following pulmonary thromboendarterectomy: a cardiac magnetic resonance imaging and invasive hemodynamic study

  Baseline (n = 20) Controls (n = 20) p value
Age (years) 61 ± 14 54 ± 9 0.07
Female, n (%) 13 (65) 10 (50) 0.34
BMI (kg/m2) 28 ± 6 24 ± 4  < 0.05
NYHA I/II/III/IV, n (%) 0/3/16/1(0/15/80/5)   
Arterial hypertension, n (%) 9 (45)   
Atrial fibrillation, n (%) 3 (15)   
COPD, n (%) 7 (35)   
Diabetes mellitus, n (%) 1 (5)   
Ischemic heart disease, n (%) 0   
Stroke, n (%) 1 (5)   
Biochemistry
 NT-ProBNP (ng/l) 890 [430; 2692]   
 Hemoglobin (mmol/l) 8.9 ± 1.4   
 Creatinine (µmol/l) 85 ± 19   
 eGFR (ml/min) 68 ± 14   
Medicine
 Warfarin, n (%) 20 (100)   
 Aspirin, n (%) 2 (10)   
 ACE/ATII inhibitor, n (%) 9 (45)   
 Loop-diuretic, n (%) 5 (25)   
 Thiazide, n (%) 4 (20)   
 Spironolactone, n (%) 2 (10)   
 Sildenafil, n (%) 1 (5)   
 Riociguat, n (%) 1 (5)   
  1. Data are presented as an absolute number and (percent) or mean ± standard deviation or median and [interquartile range]. BMI: Body Mass Index, COPD: Chronic obstructive pulmonary disease, NYHA: New York Heart Association